Clinical Trial Update: A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen) [NA]

View source ↗

Summary

Update on the ProScreen randomized trial evaluating early detection of clinically significant prostate cancer; the study is actively enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Tampere University | Conditions: Prostate Cancer | NA | Status: ENROLLING_BY_INVITATION